http://www.zibb.com/healthcare/theme/cq/Genentech+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 07 May 2008 00:00:00 GMTWed, 07 May 2008 00:00:00 GMT608831http://www.zibb.com/healthcare/theme/cq/Genentech+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.pharmaceutical-technology.com/projects/genentech/News and project information on the Genentech Inc Fill and Finish Facility, Hillsboro, Oregonhttp://www.pharmaceutical-technology.com/projects/genentech/Genentech IncorporatedWed, 07 May 2008 00:00:00 GMThttp://www.apria.com/resources/1,2725,494-863198,00.htmlGenentech Inc notified doctors of 36 cases of eye inflammation among patients who received injections with the company's Avastin colon cancer drug for unapproved eye conditions.http://www.apria.com/resources/1,2725,494-863198,00.htmlGenentech Incorporatedhttp://www.dddmag.com/mass-spec-evolution-drives-discovery.aspxNano applications, mass spectrometry-based tissue imaging, and top-down proteomics are playing a role in the progress of this toolhttp://www.dddmag.com/mass-spec-evolution-drives-discovery.aspxGenentech Incorporatedhttp://www.bio-medicine.org/medicine-technology-1/NGM-Biopharmaceuticals-Appoints-Dr--Arthur-D--Levinson--Former-Genentech-CEO--to-its-Board-of-Directors-5640-1/...SOUTH SAN FRANCISCO Calif. Oct. 21 /- NGM Biopharmaceut...Founded in 2008 NGM has created a proprietary discovery platform and ... NGM has the attributes and values that I believe are fundamental to b... Art's accomplishments and leadership during his thirty years athttp://www.bio-medicine.org/medicine-technology-1/NGM-Biopharmaceuticals-Appoints-Dr--Arthur-D--Levinson--Former-Genentech-CEO--to-its-Board-of-Directors-5640-1/Genentech IncorporatedWed, 21 Oct 2009 14:15:05 GMThttp://www.tercica.com/products/Tercica was founded to bring improved treatment options to patients who suffer from endocrine and metabolic disorders. In our first five years, we collaborated with our strategic partners to launch two novel biologic products.http://www.tercica.com/products/Genentech Incorporatedhttp://www.interphex.com/images/100026/2008_PDFs/Keynote_Burrill.pdfPublications (biotech book, newsletters, special purpose publications [stem cells, personalized medicine, aging etc.], The Journal of Life Sciences, web‐ based intelligence reports) Conferences Headcount: 60+ professionals and staff 44 Burrill & Company U.S.http://www.interphex.com/images/100026/2008_PDFs/Keynote_Burrill.pdfGenentech Incorporatedhttp://www.fda.gov/cder/drug/infopage/efalizumab/default.htmFDA has been informed by Genentech, Inc., the sponsor of Raptiva (efalizumab), of their decision to initiate a voluntary withdrawal of Raptiva. The voluntary withdrawal will occur in phases over the next several months.http://www.fda.gov/cder/drug/infopage/efalizumab/default.htmGenentech IncorporatedWed, 08 Apr 2009 22:15:00 GMThttp://www.qltinc.com/Qltinc/pages/pagespressdetail.cfm?PressID=353&YearRange=2008&InternetPageID=31QLT ANNOUNCES INTERIM RESULTS OF RADICAL STUDY EVALUATING VISUDYNE(R) COMBINATION THERAPY MEAN VISUAL ACUITY LETTER SCORES INCREASED SIMILARLY IN ALL TREATMENT GROUPS FOR IMMEDIATE RELEASE DECEMBER 16, 2008 VANCOUVER, CANADA—QLT Inc.http://www.qltinc.com/Qltinc/pages/pagespressdetail.cfm?PressID=353&YearRange=2008&InternetPageID=31Genentech Incorporatedhttp://www.hopkinskimmelcancercenter.org/index.cfm/cID/1684/mpage/item.cfm/itemID/1108One patient with the most common type of pediatric brain cancer, medulloblastoma, also showed tumor shrinkage. Initial results of the drug trial, conducted at Johns Hopkins (Baltimore), the Karmanos Cancer Center (Detroit) and the Translational Genomics Research Institute (Scottsdale, Ariz.http://www.hopkinskimmelcancercenter.org/index.cfm/cID/1684/mpage/item.cfm/itemID/1108Genentech Incorporatedhttp://www.roche.com/inv-update-2005-01-14Roche will now make Avastin available across Europe within the next few weeks and expects it to be accessible to physicians and patients early in the year.http://www.roche.com/inv-update-2005-01-14Genentech Incorporatedhttp://www.ypsomed.de/cf/342.htmlAccueil Pays ⁄ de | en | fr Contacts Plan du site Conditions d´utilisation Mention d´impression Existing Products Existing Products Injection Devices & Partners Amylin Pharmaceuticals inc. Eli Lilly and Company F. Hoffmann-La Roche Ltd. Genentech Merck Serono International S.A. Nycomed / NPShttp://www.ypsomed.de/cf/342.htmlGenentech Incorporatedhttp://www.ispe.org/page.ww?section=San+Francisco+Bay+Area+Chapter&name=Committees© 2008 International Society for Pharmaceutical Engineering. All rights reserved.http://www.ispe.org/page.ww?section=San+Francisco+Bay+Area+Chapter&name=CommitteesGenentech Incorporatedhttp://www.gene.com/gene/research/sci-profiles/research/t-lavigne/"I joined Genentech in 2003 as senior vice president, Research Drug Discovery. In this role, I oversee our research efforts in Oncology, as well as our nascent efforts in new therapeutic areas, including Tissue Growth and Repair, Neuroscience and Metabolism.http://www.gene.com/gene/research/sci-profiles/research/t-lavigne/Genentech Incorporatedhttp://www.aclara.com/130ManagementTeam.aspxWilliam D. Young is Chairman of the Board and Chief Executive Officer. He has served as our Chief Executive Officer since November 1999 and has served as the Chairman of the Board since May 1999. From March 1997 to October 1999, Mr. Young was Chief Operating Officer at Genentech, Inc.http://www.aclara.com/130ManagementTeam.aspxGenentech Incorporatedhttp://www.clinicalassistance.com/clinical-trials-for-avastin.phpAvastin Clinical Trial Information Clinical trials are important because they help doctors learn more about cancer and can lead to ... What is a clinical trial for patients with cancer? A clinical trial is medical research in a clinic ... http://www.avastin.com/avastin/crcClinicalTrials.mhttp://www.clinicalassistance.com/clinical-trials-for-avastin.phpGenentech Incorporatedhttp://www.flakehq.com/raptiva032104.htmSOUTH SAN FRANCISCO, CA and BERKELEY, CA – March 21, 2004 - Genentech, Inc. (NYSE: DNA) and XOMA Ltd. (Nasdaq: XOMA) today announced preliminary results of a randomized, placebo-controlled Phase II study with RAPTIVA(tm) (efalizumab) in 107 patients with psoriatic arthritis.http://www.flakehq.com/raptiva032104.htmGenentech Incorporatedhttp://www.ndhnow.com/duw_ranibizumabinjection.htmNEW WARNING Genentech issued a Dear Health Care Provider letter about new safety information related to the monoclonal antibody ranibizumab (Lucentis), indicated for wet age-related macular degeneration. Postmarketing studies showed a higher incidence of stroke in patients treated with the higher 0.http://www.ndhnow.com/duw_ranibizumabinjection.htmGenentech Incorporatedhttp://www.onsite-dental.com/Genentech.htmlYou can request an appointment online below, or to request an appointment by phone, please call our practice manager Elvie McCallion at (650) 208-0583.http://www.onsite-dental.com/Genentech.htmlGenentech Incorporatedhttp://www.cvt.com/m_management.htmlDr. Louis Lange is a founder of CV Therapeutics and has served as the Chairman of the Board and Chief Executive Officer since August 1992. From 1980 to 1992, Dr.http://www.cvt.com/m_management.htmlGenentech Incorporatedhttp://www.plexxicon.com/management.htmlChief Executive Officer Dr. Hirth co-founded Plexxikon in December 2000, and has more than 25 years of biotechnology and pharmaceutical discovery and development experience. Previously, he was president of Sugen, Inc. until the sale of the company to Pharmacia Corporation in 1999.http://www.plexxicon.com/management.htmlGenentech Incorporatedhttp://www.flad.com/project_simple.php?ProjectID=20A biotechnology company based in South San Francisco, Genentech sough counsel to establish development opportunities for their research facility growth on the mid-campus site.http://www.flad.com/project_simple.php?ProjectID=20Genentech Incorporatedhttp://www.drugs.com/NDA/tarceva_040802.htmlDrugs.com - prescription drug and over the counter medicine information available on over 24,000 approved medications and pharmaceuticals, including side effects and drug interactions.http://www.drugs.com/NDA/tarceva_040802.htmlGenentech Incorporatedhttp://www.arraybiopharma.com/Collaboration/AstraZenecaDeal.aspAstraZeneca – MEK for Cancer Program / AZD6244 (ARRY-886) and AZD8330 (ARRY-704) In December 2003, we entered into an out-licensing and collaboration agreement with AstraZeneca to develop our MEK program solely in the field of oncology.http://www.arraybiopharma.com/Collaboration/AstraZenecaDeal.aspGenentech Incorporatedhttp://www.biotechpatent.com/sept05/article16.htmlGenentech, Inc. (S. San Francisco, CA) provided information on the pending reexamination of the Cabilly, et al. United States Patent 6,331,415 ('415 patent), which was ordered by the United States Patent and Trademark Office on July 7, 2005.http://www.biotechpatent.com/sept05/article16.htmlGenentech Incorporatedhttp://www.biocon.com/biocon_press_archive_details.asp?Fileid=100Kiran Mazumdar-Shaw is founder and chairman and managing director of the Bangalore-based Biocon Ltd.India's first biotechnology company to be listed on the stock exchange.http://www.biocon.com/biocon_press_archive_details.asp?Fileid=100Genentech Incorporated